Abstract
We report the occurrence of skin toxicities in pediatric oncology patients on concomitant treatment with voriconazole and methotrexate (MTX). Of 23 patients who received this combination, 11 patients suffered from cheilitis and/or photosensitivity. In contrast, only in 1 of 9 patients who received voriconazole without MTX was photosensitivity observed. A mechanism of action was not able to be identified. We describe two cases with severe skin toxicities. Caution is warranted when using voriconazole and concomitant MTX.
| Original language | English |
|---|---|
| Pages (from-to) | 2878-2881 |
| Number of pages | 4 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 57 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2013 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver